- Home
- LIN vs MRK Comparison
LIN vs MRK Comparison
Compare LIN & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIN
- MRK
- Stock Information
- Founded
- LIN 1879
- MRK 2000
- Country
- LIN United Kingdom
- MRK United States
- Employees
- LIN N/A
- MRK N/A
- Industry
- LIN Major Chemicals
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- LIN Industrials
- MRK Health Care
- Exchange
- LIN Nasdaq
- MRK Nasdaq
- Market Cap
- LIN 218.9B
- MRK 260.8B
- IPO Year
- LIN N/A
- MRK N/A
- Fundamental
- Price
- LIN $424.31
- MRK $98.13
- Analyst Decision
- LIN Buy
- MRK Buy
- Analyst Count
- LIN 13
- MRK 15
- Target Price
- LIN $491.90
- MRK $129.07
- AVG Volume (30 Days)
- LIN 2.4M
- MRK 13.2M
- Earning Date
- LIN 02-04-2025
- MRK 02-04-2025
- Dividend Yield
- LIN 1.31%
- MRK 3.30%
- EPS Growth
- LIN 8.95
- MRK 165.47
- EPS
- LIN 13.18
- MRK 4.78
- Revenue
- LIN $33,025,000,000.00
- MRK $63,174,000,000.00
- Revenue This Year
- LIN $2.14
- MRK $7.49
- Revenue Next Year
- LIN $5.20
- MRK $4.97
- P/E Ratio
- LIN $32.20
- MRK $20.51
- Revenue Growth
- LIN 1.77
- MRK 6.51
- 52 Week Low
- LIN $396.07
- MRK $94.48
- 52 Week High
- LIN $487.49
- MRK $134.63
- Technical
- Relative Strength Index (RSI)
- LIN 29.62
- MRK 40.69
- Support Level
- LIN $437.25
- MRK $97.82
- Resistance Level
- LIN $461.90
- MRK $101.50
- Average True Range (ATR)
- LIN 6.89
- MRK 2.19
- MACD
- LIN -2.30
- MRK -0.19
- Stochastic Oscillator
- LIN 13.84
- MRK 4.28
About LIN Linde plc
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $33 billion in revenue in 2023.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.